Issue of Equity

RNS Number : 3586E
Maven Income and Growth VCT 3 PLC
10 March 2022
 


Maven Income and Growth VCT 3 PLC (the Company)

 

Issue of Equity

 

On 20 September 2021, the Company launched an offer for subscription for new ordinary shares of 10p each (Ordinary Shares) to raise up to £10 million, with an over-allotment facility for up to a further £10 million (the Offer). On 31 January 2022, it was announced that the Directors had resolved to utilise the over-allotment facility to the extent required to meet further investor demand, and an initial allotment of Ordinary Shares under the Offer took place on 4 February 2022.

 

The Board of the Company has resolved that an additional allotment of shares will now take place on 22 March 2022, in respect of all valid applications received, together with their relevant application monies for the 2021/2022 tax year, by close of business on 18 March 2022.

 

The Board also intends that a final allotment in respect of applications for the 2021/2022 tax year will take place on or before 5 April 2022. It is also intended that an allotment in respect of applications for the 2022/2023 tax year will take place as soon practicable after the close of the Offer, which is expected to be on 3 June 2022 unless the Offer is fully subscribed by an earlier date or extended, at the Board's discretion, to a date up to and including 9 September 2022.

 

Further information

 

Any enquiries in respect of the Offer, or requests for copies of the Prospectus documents (available free of charge), should be directed to:

 

Maven Capital Partners UK LLP

Kintyre House

205 West George Street

Glasgow

G2 2LW

 

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

 

Downloadable versions of the Prospectus documents are available from the Maven website at: www.mavencp.com/vctoffer .

 

Maven Capital Partners UK LLP

Secretary

 

10 March 2022

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFLFLLVRIILIF
UK 100